Abstract
Half of the global population is at risk for malaria, which results in nearly one million deaths annually, 86 % of which are in children [1]. Plasmodium falciparum, the most important human malaria parasite, is transmitted by female Anopheles mosquitoes. Parasite development in the mosquito begins with the ingestion of blood containing sexualstage gametocytes. Mobile ookinetes penetrate the midgut epithelium 24–36 h later and transform into midgut-bound oocysts within the open circulatory system of the mosquito. Oocysts grow and develop for 10–12 days and then release thousands of sporozoites, which invade the salivary glands and are released during later blood feeding by the mosquito.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (2011) World Health Organization Malaria Report. World Health Organization, Geneva, Switzerland
Gooding LR (1992) Virus proteins that counteract host immune defenses. Cell 71:5–7
Akman-Anderson L, Vodovotz Y, Zamora R, Luckhart S (2007) Bloodfeeding as an interface of mammalian and arthropod immunity. In: Beckage N (ed) Insect immunology. Elsevier, San Diego, CA, pp 149–177
Pakpour N, Akman-Anderson L, Vodovotz Y, Luckhart S (2013) The effects of ingested mammalian blood factors on vector arthropod immunity and physiology. Microbes Infect 15 (3):243–254
Hurd H, Taylor PJ, Adams D, Underhill A, Eggleston P (2005) Evaluating the costs of mosquito resistance to malaria parasites. Evolution 59(12):2560–2572
Voordouw MJ, Koella JC, Hurd H (2008) Comparison of male reproductive success in malaria-refractory and susceptible strains of Anopheles gambiae. Malar J 7:103
Corby-Harris V, Drexler A, de Watkins JL, Antonova Y, Pakpour N, Ziegler R et al (2010) Activation of Akt signaling reduces the prevalence and intensity of malaria parasite infection and lifespan in Anopheles stephensi mosquitoes. PLoS Pathog 6(7):e1001003
Vodovotz Y, Zamora R, Lieber MJ, Luckhart S (2004) Cross-talk between nitric oxide and transforming growth factor-b1 in malaria. Curr Mol Med 4:787–797
Luckhart S, Crampton AL, Zamora R, Lieber MJ, Dos Santos PC, Peterson TML et al (2003) Mammalian transforming growth factor-b1 activated after ingestion by Anopheles stephensi modulates mosquito immunity. Infect Immun 71:3000–3009
Lim J, Gowda DC, Krishnegowda G, Luckhart S (2005) Induction of nitric oxide synthase in Anopheles stephensi by Plasmodium falciparum: mechanism of signaling and the role of parasite glycosylphosphatidylinositols. Infect Immun 73(5):2778–2789
Luckhart S, Lieber MJ, Singh N, Zamora R, Vodovotz Y (2008) Low levels of mammalian TGF-b1 are protective against malaria parasite infection, a paradox clarified in the mosquito host. Exp Parasitol 118:290–296
Kang M-A, Mott TM, Tapley EC, Lewis EE, Luckhart S (2008) Human insulin regulates oxidative stress and aging in the mosquito Anopheles stephensi. J Exp Biol 211:741–748
Akman-Anderson L, Olivier M, Luckhart S (2007) Induction of nitric oxide synthase and activation of signaling proteins in Anopheles mosquitoes by the malaria pigment, hemozoin. Infect Immun 75(8):4012–4019
Azhar N, Vodovotz Y (2012) Innate immunity in disease: insights from mathematical modeling and analysis. In: Corey S (ed) A systems approach to blood. Springer, New York
An G, Nieman G, Vodovotz Y (2012) Computational and systems biology in trauma and sepsis: current state and future perspectives. Int J Burns Trauma 2:1–10
An G, Nieman G, Vodovotz Y (2012) Toward computational identification of multiscale tipping points in multiple organ failure. Ann Biomed Eng 40:2412–2424
Drexler AL, Vodovotz Y, Luckhart S (2008) Plasmodium development in the mosquito: biology bottlenecks and opportunities for mathematical modeling. Trends Parasitol 24:333–336
Moreira LA, Ghosh AK, Abraham EG, Jacobs-Lorena M (2002) Genetic transformation of mosquitoes: a quest for malaria control. Int J Parasitol 32(13):1599–1605
Catteruccia F (2007) Malaria vector control in the third millennium: progress and perspectives of molecular approaches. Pest Manag Sci 63(7):634–640
malERA Consultative Group on Vector Control (2011) A research agenda for malaria eradication: vector control. PLoS Med 8(1):e1000401
Mideo N, Day T, Read AF (2008) Modelling malaria pathogenesis. Cell Microbiol 10(10): 1947–1955
Date SV, Stoeckert CJ (2006) Computational modeling of the Plasmodium falciparum interactome reveals protein function on a genome-wide scale. Genome Res 16(4):542–549
LaCount DJ, Vignali M, Chettier R, Phansalkar A, Bell R, Hesselberth JR et al (2005) A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 438(7064):103–107
Hu G, Cabrera A, Kono M, Mok S, Chaal BK, Haase S et al (2010) Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum. Nat Biotechnol 28(1):91–98
Osta MA, Christophides GK, Vlachou D, Kafatos FC (2004) Innate immunity in the malaria vector Anopheles gambiae: comparative and functional genomics. J Exp Biol 207(15):2551–2563
Zdobnov EM, von Mering C, Letunic I, Torrents D, Suyama M, Copley RR et al (2002) Comparative genome and proteome analysis of Anopheles gambiae and Drosophila melanogaster. Science 298(5591):149–159
Winzeler EA (2006) Applied systems biology and malaria. Nat Rev Microbiol 4(2):145–151
Osta MA, Christophides GK, Kafatos FC (2004) Effects of mosquito genes on Plasmodium development. Science 303(5666):2030–2032
Horton AA, Wang B, Camp L, Price MS, Arshi A, Nagy M et al (2011) The mitogen-activated protein kinome from Anopheles gambiae: identification, phylogeny and functional characterization of the ERK, JNK and p38 MAP kinases. BMC Genomics 12:574
Surachetpong W, Singh N, Cheung KW, Luckhart S (2009) MAPK ERK signaling regulates the TGF-beta1-dependent mosquito response to Plasmodium falciparum. PLoS Pathog 5(4):e1000366
Surachetpong W, Pakpour N, Cheung KW, Luckhart S (2011) Reactive oxygen species-dependent cell signaling regulates the mosquito immune response to Plasmodium falciparum. Antioxid Redox Signal 14(6):943–955
Omer FM, Kurtzhals JA, Riley EM (2000) Maintaining the immunological balance in parasitic infections: a role for TGF-b? Parasitol Today 16(1):18–23
Lieber MJ, Luckhart S (2004) Transforming growth factor-betas and related gene products in mosquito vectors of human malaria parasites: signaling architecture for immunological crosstalk. Mol Immunol 41(10):965–977
Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN et al (2002) A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360(9344):1468–1475
Lopansri BK, Anstey NM, Weinberg JB, Stoddard GJ, Hobbs MR, Levesque MC et al (2003) Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 361(9358):676–678
Yeo TW, Lampah DA, Tjitra E, Gitawati R, Darcy CJ, Jones C et al (2010) Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog 6(4):e1000868
Luckhart S, Vodovotz Y, Cui L, Rosenberg R (1998) The mosquito Anopheles stephensi limits malaria parasite development with inducible synthesis of nitric oxide. Proc Natl Acad Sci USA 95:5700–5705
Peterson TM, Gow AJ, Luckhart S (2007) Nitric oxide metabolites induced in Anopheles stephensi control malaria parasite infection. Free Radic Biol Med 42(1):132–142
Mu Y, Gudey SK, Landstrom M (2012) Non-Smad signaling pathways. Cell Tissue Res 347(1):11–20
Price I, Ermentrout B, Zamora R, Wang B, Azhar N, Mi Q, Constantine G, Faeder J, Luckhart S, Vodovotz Y (2013) In vivo, in vitro, and in silico studies suggest a conserved immune modulethat may regulate malaria parasite transmission from mammals to mosquitoes. J Theor Bio (in press)
Crampton AL, Luckhart S (2001) Isolation and characterization of As60A, a transforming growth factor-b gene, from the malaria vector Anopheles stephensi. Cytokine 13(2):65–74
Koch-Nolte F, Fischer S, Haag F, Ziegler M (2011) Compartmentation of NAD+-dependent signalling. FEBS Lett 585(11):1651–1656
Zolkiewska A (2005) Ecto-ADP-ribose transferases: cell-surface response to local tissue injury. Physiology (Bethesda) 20:374–381
Bruzzone S, Franco L, Guida L, Zocchi E, Contini P, Bisso A et al (2001) A self-restricted CD38-connexin 43 cross-talk affects NAD+ and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts. J Biol Chem 276(51):48300–48308
Romanello M, Padoan M, Franco L, Veronesi V, Moro L, D’Andrea P (2001) Extracellular NAD+ induces calcium signaling and apoptosis in human osteoblastic cells. Biochem Biophys Res Commun 285(5):1226–1231
Berg S, Sappington PL, Guzik LJ, Delude RL, Fink MP (2003) Proinflammatory cytokines increase the rate of glycolysis and adenosine-5′-triphosphate turnover in cultured rat enterocytes. Crit Care Med 31(4):1203–1212
Guse AH, da Silva CP, Emmrich F, Ashamu GA, Potter BV, Mayr GW (1995) Characterization of cyclic adenosine diphosphate-ribose-induced Ca2+ release in T lymphocyte cell lines. J Immunol 155(7):3353–3359
Takasawa S, Nata K, Yonekura H, Okamoto H (1993) Cyclic ADP-ribose in insulin secretion from pancreatic beta cells. Science 259(5093):370–373
Franco L, Guida L, Bruzzone S, Zocchi E, Usai C, de Flora A (1998) The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes. FASEB J 12(14):1507–1520
Franco L, Zocchi E, Usai C, Guida L, Bruzzone S, Costa A et al (2001) Paracrine roles of NAD+ and cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts. J Biol Chem 276(24):21642–21648
Higashida H, Hashii M, Yokoyama S, Hoshi N, Chen XL, Egorova A et al (2001) Cyclic ADP-ribose as a second messenger revisited from a new aspect of signal transduction from receptors to ADP-ribosyl cyclase. Pharmacol Ther 90(2–3):283–296
Berger F, Ramirez-Hernandez MH, Ziegler M (2004) The new life of a centenarian: signalling functions of NAD(P). Trends Biochem Sci 29(3):111–118
Maehama T, Nishina H, Hoshino S, Kanaho Y, Katada T (1995) NAD+-dependent ADP-ribosylation of T lymphocyte alloantigen RT6.1 reversibly proceeding in intact rat lymphocytes. J Biol Chem 270(39):22747–22751
Rigby MR, Bortell R, Stevens LA, Moss J, Kanaitsuka T, Shigeta H et al (1996) Rat RT6.2 and mouse Rt6 locus 1 are NAD+: arginine ADP ribosyltransferases with auto-ADP ribosylation activity. J Immunol 156(11):4259–4265
Okazaki IJ, Moss J (1998) Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases. J Biol Chem 273(37):23617–23620
Grimaldi JC, Balasubramanian S, Kabra NH, Shanafelt A, Bazan JF, Zurawski G et al (1995) CD38-mediated ribosylation of proteins. J Immunol 155(2):811–817
Bruzzone S, Moreschi I, Guida L, Usai C, Zocchi E, de Flora A (2006) Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes. Biochem J 393(Pt 3):697–704
Higashida H, Hashii M, Yokoyama S, Hoshi N, Asai K, Kato T (2001) Cyclic ADP-ribose as a potential second messenger for neuronal Ca2+ signaling. J Neurochem 76(2):321–331
Zamora R, Azhar N, Namas R, Metukuri MR, Clermont T, Gladstone C et al (2012) Identification of a novel pathway of TGF-beta1 regulation by extracellular NAD+ in mouse macrophages: in vitro and in silico studies. J Biol Chem 287:31003–31014
Grzegorczyk M, Husmeier D (2011) Improvements in the reconstruction of time-varying gene regulatory networks: dynamic programming and regularization by information sharing among genes. Bioinformatics 27(5):693–699
Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR et al (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336(8725):1201–1204
Walley AJ, Aucan C, Kwiatkowski D, Hill AV (2004) Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case–control study. Eur J Hum Genet 12(2):132–138
Niikura M, Inoue S, Kobayashi F (2011) Role of interleukin-10 in malaria: focusing on coinfection with lethal and nonlethal murine malaria parasites. J Biomed Biotechnol 2011:383962
Freitas do Rosario AP, Langhorne J (2012) T cell-derived IL-10 and its impact on the regulation of host responses during malaria. Int J Parasitol 42(6):549–555
Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA et al (2008) Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA 105(12):4814–4819
Dunachie SJ, Berthoud T, Keating SM, Hill AV, Fletcher HA (2010) MIG and the regulatory cytokines IL-10 and TGF-beta1 correlate with malaria vaccine immunogenicity and efficacy. PLoS One 5(9):e12557
Darby SM, Miller ML, Allen RO, LeBeau M (2001) A mass spectrometric method for quantitation of intact insulin in blood samples. J Anal Toxicol 25(1):8–14
White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S et al (1983) Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 309(2):61–66
Drexler A, Nuss A, Hauck E, Glennon E, Cheunk K, Brown M et al (2013) Human IGF1 extends lifespan and enhances resistance to Plasmodium falciparum infection in the malaria vector Anopheles stephensi. J Exp Biol 216(Pt 2):208–217
Beier MS, Pumpuni CB, Beier JC, Davis JR (1994) Effects of para-aminobenzoic acid, insulin, and gentamicin on Plasmodium falciparum development in anopheline mosquitoes (Diptera: Culicidae). J Med Entomol 31(4):561–565
Marquez AG, Pietri JE, Smithers HM, Nuss A, Antonova Y, Drexler AL et al (2011) Insulin-like peptides in the mosquito Anopheles stephensi: identification and expression in response to diet and infection with Plasmodium falciparum. Gen Comp Endocrinol 173(2):303–312
Holly JM, Perks CM (2012) Insulin-like growth factor physiology: what we have learned from human studies. Endocrinol Metab Clin North Am 41(2):249–263, v
Zechner D, Craig R, Hanford DS, McDonough PM, Sabbadini RA, Glembotski CC (1998) MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem 273(14):8232–8239
Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H et al (1999) Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 274(38):27161–27167
Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA et al (2002) Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem 277(17):14884–14893
Lang R, Hammer M, Mages J (2006) DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 177(11):7497–7504
Hagemann C, Blank JL (2001) The ups and downs of MEK kinase interactions. Cell Signal 13(12):863–875
Zhuang ZH, Sun L, Kong L, Hu JH, Yu MC, Reinach P et al (2006) Drosophila TAB2 is required for the immune activation of JNK and NF-kappaB. Cell Signal 18(7):964–970
Javelaud D, Mauviel A (2005) Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 24(37):5742–5750
Albert I, Thakar J, Li S, Zhang R, Albert R (2008) Boolean network simulations for life scientists. Source Code Biol Med 3:16
Saez-Rodriguez J, Alexopoulos LG, Epperlein J, Samaga R, Lauffenburger DA, Klamt S et al (2009) Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol Syst Biol 5:331
Miskov-Zivanov N, Marculescu D, Faeder JR (2013) Dynamic behavior of cell signaling networks: model design and analysis automation. In: Proceedings of the 50th Annual Design Automation Conference (DAC ‘13). ACM, New York, NY, USA, Article 8, p. 6. doi:10.1145/2463209.2488743 http://doi.acm.org/10.1145/2463209.2488743
Miskov-Zivanov N, Bresticker A, Venkatakrishnan S, Kashinkunti P, Krishnaswamy D, Marculescu D et al (2011) Regulatory network analysis acceleration with reconfigurable hardware. In: Proceedings of international conference of the IEEE Engineering in Medicine and Biology Society, pp 149–152
Miskov-Zivanov N, Bresticker A, Krishnaswamy D, Venkatakrishnan S, Marculescu D, Faeder JR (2011) Emulation of biological networks in reconfigurable hardware. In: Proceedings of ACM conference on bioinformatics, computational biology and biomedicine, pp 536–540
Clarke EM, Grumberg O, Peled D (1999) Model checking. MIT Press, Cambridge, MA
Gong H, Zuliani P, Wang Q, Clarke EM (2011) Formal analysis for logical models of pancreatic cancer. In: 50th IEEE conference on decision and control and European control conference, pp 4855–4860
Luckhart S, Giulivi C, Drexler AL, Antonova-Koch Y, Sakaguchi D, Napoli E, Wong S, Price MS, Eigenheer R, Phinney BS, Pakpour N, Pietri JE, Cheung K, Georgis M, Riehle M (2013 Feb) Sustained activation of Akt elicits mitochondrial dysfunction to block Plasmodium falciparum infection in the mosquito host. PLoS Pathog 9(2):e1003180(2):e1003180(2):e1003180
Dong Y, Das S, Cirimotich C, Souza-Neto JA, McLean KJ, Dimopoulos G (2011) Engineered Anopheles immunity to Plasmodium infection. PLoS Pathog 7(12):e1002458
Acknowledgments
This work was supported by NIH grant R01-AI080799.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Vodovotz, Y. et al. (2013). Modeling Host–Vector–Pathogen Immuno-inflammatory Interactions in Malaria. In: Vodovotz, Y., An, G. (eds) Complex Systems and Computational Biology Approaches to Acute Inflammation. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8008-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8008-2_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8007-5
Online ISBN: 978-1-4614-8008-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)